Somaxon Pharmaceuticals (SOMX) Misses Q1 Views
Tweet
Share
E-mailGet Alerts SOMX Hot Sheet
Join SI Premium – FREE
Somaxon Pharmaceuticals (Nasdaq: SOMX) reported Q1 loss of ($0.38), $0.03 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.22 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
